This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 3 from Patent US 20050239703
General Information
DRACP ID DRACP01253
Peptide Name Sequence 3 from Patent US 20050239703
Sequence ELKCYTCKEPMTSAACRTIT
Sequence Length 20
UniProt ID Not available
PubChem CID Not available
Origin Synthetic construct
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Not available
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification None
Chiral L
Physicochemical Information
Formula C93H157N25O31S4
Absent amino acids DFGHNQVW
Common amino acids T
Mass 258874
Pl 8.04
Basic residues 3
Acidic residues 2
Hydrophobic residues 4
Net charge 1
Boman Index -3381
Hydrophobicity -22.5
Aliphatic Index 49
Half Life
Mammalian: 1.2 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 1615
Absorbance 280nm 85
Polar residues 9
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2005/0239703 A1
Patent Title Anticancer peptide compositions.
Other Iinformation Granted Patent Family: 3s / 3ex; Family Jurisdictions: US, WO; Legal Status: Inactive; Application No: 97762904; Filed:Oct 29, 2004; Published: Oct 27, 2005; Earliest Priority: Oct 29, 2003; Granted: Feb 5, 2008
Other Published ID US7326679 WO2005042001A1
This work is licensed under a Creative Commons Attribution 4.0 International License.